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Abstract 
Treatment of rat parotid tissues with 1 p~M isoproterenol (IPR) for 10 min caused a 60% decrease in pertussis toxin (IAP)-catalyzed 
ADP-ribosylation of Gia and resulted in supersensitivity of amylase secretion from the tissues. However, conversely, IPR treatment for 
30 rain caused a40% increase in IAP-catalyzed ADP-fibosylation of Gic¢, coupled with desensitization of amylase secretion. No changes 
in Gs function were observed in IPR-induced phenomena. Pretreatment with okadaic acid induced enhancement of the supersensitivity of 
amylase secretion and disappearance of the desensitization. These phenomena were accompanied with decreases in IAP-catalyzed 
ADP-ribosylation of Gia. IPR treatment for 30 min caused a 50% decrease in phosphorylation f Gi2c~ immunoprecipitated with anti-G 
protein antiserum (AS/7) from [32P]Pi-labeled cells, but such treatment for 10 min caused a40% increase in phosphorylation in the cells 
pretreated with okadaic acid. Phosphorylation a d dephosphorylation of immunoprecipitates with AS/7 by protein kinase A (PKA) and 
alkaline phosphatase caused decreases and increases in IAP-catalyzed ADP-ribosylation, respectively, indicating the presence of 
PKA-mediated phosphorylation sites on Gi2c~. Thus, the control of the phosphorylation f Gi2cx is of importance and relevance in the 
regulation of biological processes and cellular esponses. 
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I. Introduction 
It has been shown that desensitization mediated by 
neurotransmitter r ceptors uch as eL- and [3-adrenoceptors 
and muscarinic acetylcholine receptors results in the de- 
creases in the numbers of these respective receptors and in 
the cellular responses. Desensitization is a phenomenon 
which occurs widely in response to a variety of stimuli and 
is found in many kinds of organisms, indicating the impor- 
tance of it in cell signaling. In the rat parotid gland, 
desensitization of K + release occurs in response to a-  or 
[3-adrenergic or muscarinic holinergic stimuli [1]. Desen- 
sitization of salivary secretion in response to IPR was also 
induced by repeated administration of tricyclic antidepres- 
sant [2]. On the other hand, increases in the tissue re- 
sponses develop in for example exocrine glands, skeletal 
and smooth muscles and neurons after chronic interruption 
of neuronal input by denervation in mammals. In rat 
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parotid glands, supersensitivities of salivary secretion and 
amylase secretion develop after parasympathetic [3] and 
sympathetic [4] denervation, respectively. Supersensitivity 
of salivary secretion was also reported to occur following 
sympathetic nerve stimulation after partial sympathetic 
ganglionectomy [5]. These findings suggest hat only the 
[3-adrenoceptor-mediated response of amylase secretion 
becomes upersensitive after chronic sympathetic denerva- 
tion. However, the mechanisms of salivary gland dysfunc- 
tion are not known clearly. It was reported previously that 
short-term treatment of rat parotid tissues with isoprote- 
renol (IPR) for less than 10 min resulted in supersensitivity 
of amylase secretion from the tissues, but such treatment 
for more than 20 min resulted in desensitization [6]. These 
phenomena were accompanied by alterations in the num- 
ber of 13-adrenoceptors in the tissues and in the affinity of 
these receptors for their agonists, but with no changes in 
adenylate cyclase (AC) activity [6], showing that this 
experimental model has a physiological relevance to study 
the regulatory mechanism of cellular functioning. 
Guanine-nucleotide-binding proteins (G proteins) are 
known to have important regulatory roles in receptor-medi- 
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ated signal transduction as coupling proteins. These pro- 
teins are heterotrimers consisting of u, [3 and ",/ subunits, 
and comprise a family which includes stimulatory G pro- 
teins (Gs), inhibitory G proteins (Gi), G proteins (Go) to 
other effectors and G proteins (Gq) coupled to phospholi- 
pase and many other G proteins. Gs is the substrate for 
ADP-ribosylation by cholera toxin (CT) and mediates the 
stimulation of AC by [3-agonists, while Gi is the substrate 
for ADP-ribosylation by pertussis toxin (IAP) and medi- 
ates the inhibition of AC by cx2-agonists. Go is also an 
lAP-sensitive G protein, but does not inhibit AC. Gq is 
lAP-insensitive and is responsible for regulation of phos- 
pholipase C[3 [7]. Recently.. attention has been focused on 
the postreceptor mechanisms involved in changes in the 
levels of G proteins coupled with desensitization. We 
reported previously that the enhancement of Gi protein 
function was coupled with ~Ihe IPR-induced esensitization 
of mucin secretion from rat submandibular glands and that 
the function of Gi proteins appeared to be controlled by 
their phosphorylation level [8]. However, it remains to be 
established whether changes in phosphorylation level of Gi 
proteins and their function are involved in the mechanism 
underlying IPR-induced alteration of cellular responses in 
rat parotid tissues. In this sludy, we investigated the mech- 
anisms responsible for the up- and down-regulation of 
signal transduction from supersensitivity to desensitization 
of amylase secretion from rat parotid tissues induced by 
IPR. Regulation of the phosphorylation level of Gi proteins 
modified by protein kinase A (PKA) or protein ph6s- 
phatase played an important key role in the modulation of 
the cellular responses to subsequent stimulation by [3- 
agonists. 
2. Materials and methods 
2.1. Preparation and incubation of rat parotid tissues 
Male Wistar rats (8 wk old) were given laboratory chow 
(MF, Oriental Yeast Co., Tokyo, Japan) and water ad 
libitum and maintained in a temperature-controlled envi- 
ronment (22 ___ 2°C) with a 12-h light/dark cycle (light on 
from 6:00 a.m. to 6:00 p.m.) before experiments. The 
parotid glands were rapidly removed from rats killed by a 
blow to the head and transferred into ice-cold Krebs-Ringer 
Tris (KRT) solution consisl:ing of 120 mM NaC1, 4.8 mM 
KC1, 1.2 mM KH2PO4, 1.2 mM MgSO 4, 3.0 mM CaCI 2, 
16 mM Tris-HCl buffer (pH 7.4) and 5 mM glucose. 
Before the experiments, the KRT solution was aerated with 
02 gas, and the tissue slices (0.4 mm thick) prepared from 
the parotid glands with a McIlwain Tissue Chopper (The 
Mickle Laboratory Engineering Co., UK) were equili- 
brated with the solution for 20 rain at 370C with shaking. 
Tissue slices were treated with IPR under the conditions 
described previously [6]. Briefly, the slices (50 rag) were 
incubated for 10 or 30 rain at 37°C in 10 ml of KRT 
solution with or without 1 IxM IPR (first incubation, or 
IPR pretreatment). After washing well with KRT solution, 
the slices were transferred into normal KRT solution for 
10 min at 37°C (rest period) and then challenged by 
incubation with 1 I~M IPR (second incubation, or IPR 
treatment). In some experiments, the slices were preincu- 
bated with 0.05 to 0.2 IxM okadaic acid for 30 min at 37°C 
and then treated with IPR as described above. At time zero 
and at the end of incubation of the tissue slices, aliquots of 
the medium were used to determine amylase activity. 
2.2. ADP-ribosylation of G proteins 
After the first and second incubations, the tissue slices 
were homogenized in 50 mM Tris-HC1 buffer (pH 7.4) 
with 10 mM MgC12 and 1 mM dithiothreitol (DTT) (buffer 
A) using a glass homogenizer with a Teflon pestle, fol- 
lowed by centrifugation twice at 48 000 × g for 10 min to 
remove the cell supernatant. The resulting pellets sus- 
pended in buffer A were filtered through a single layer of 
nylon bolting cloth (150 mesh) and used as the tissue 
membranes. ADP-ribosylation of Gs proteins was per- 
formed according to the method of Pyne et al. [9]. Briefly, 
the final suspension (5 mg protein) was suspended in 600 
ILl of reaction mixture consisting of 150 mM KH2PO 4 (pH 
7.6), 3 mM DTT, 5 p,M CaC12, 1 mM MgC12, 7.5 mM 
thymidine and 6.7 ~M [32 P]NAD, followed by incubation 
for 45 min at 37°C with CT (66 txg) which had been 
preactivated for 10 min at 37°C with 50 mM DTT. ADP- 
ribosylation of Gi proteins was performed by the method 
of Ribeiro-Neto et al. [ 10], as follows. The final suspension 
(5 mg protein) in 600 ILl of 25 mM Tris-HCl buffer (pH 
7.4), 50 mM KH2PO 4, 2 mM DTT, 1 mM ATP, 1 mM 
EDTA (pH 7.4), 100 IxM GTP, 10 mM MgC12, 10 mM 
thymidine, 1 mM ADP-ribose and 6.7 p,M [32p]NAD was 
incubated for 1 h at 30°C with lAP (25 txg) which had 
been preactivated for 20 rain at 30°C with 5 mM ATP and 
20 mM DTT. The ADP-ribosylation reactions were stopped 
by addition of trichloroacetic a id (TCA) at a final concen- 
tration of 6%. The mixtures were allowed to stand for 30 
min on ice after the addition of TCA and then centrifuged 
at 3,000 rpm for 20 min at 4°C. The resulting pellets were 
washed twice with ethyl ether saturated with H20 and 
collected by centrifugation. The remaining ethyl ether was 
allowed to evaporate and the final pellets were dissolved 
without heating in 960 Ixl of solubilizing buffer consisting 
of 62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate 
(SDS), 10% glycerol and 0.04% CHAPS, and then mixed 
with 50 txl of mercaptoethanol and 10 ILl of 0.1% bro- 
mophenol blue. Two hundred ~1 aliquots of samples were 
loaded in each lane and subjected to SDS-polyacrylamide 
gel electrophoresis (PAGE) in 12.5% linear polyacryl- 
amide gels. After electrophoresis, the bottom part of the 
gel containing [32p]NAD was cut off and the remainder of 
the gel was stained with 0.25% Amido Black 10B. The gel 
was destained, and the location and the intensity of the 
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radioactive peptides were analyzed with a thin layer scan- 
ner (Bertholt, Germany). The intensity of 32 P-imaging of 
radiolabeled substrates for each bacterial toxin was evalu- 
ated by measuring the peak areas with an image analyzer 
(Luzex 500, Nireco, Japan). In some cases, the gel was 
exposed variably to Kodak X-ray film with an intensifying 
screen at -80  °C. The radioactive peptides in the auto- 
radiograms were analyzed with a chromatoscanner (CS- 
930, Shimadzu, Japan) and the intensity was evaluated by 
measuring the peak areas of absorbance with an image 
analyzer. 
2.3. Phosphorylation and dephosphorylation f membrane 
proteins 
The tissue membrane proteins were phosphorylated ac- 
cording to the method of Watanabe t al. [11]. Briefly, the 
membranes (5 mg protein) prepared from the tissue frag- 
ments after the first and the second incubations with or 
without IPR were suspended in a phosphorylation mixture 
consisting of 50 mM triethanolamine-HCl buffer (pH 7.4), 
10 mM MgCI 2, 1 mM EDTA (pH 7.4), and 1 mM ATP 
with PKA catalytic subunit (25 U) and were incubated for 
30 min at 25°C. To dephosphorylate Gi proteins, the tissue 
membranes were suspended in a reaction mixture consist- 
ing of 50 mM Tris-HC1 buffer (pH 7.5), 5 mM MgC12 and 
0.5 or 1.0 unit of ALPase, followed by incubation for 10 
min at 30°C. After completion of the reactions, the mem- 
branes were washed twice with 10 mM Tris-HC1 buffer 
(pH 7.4) containing 5 mM MgC12 and 1 mM DTT by 
centrifugation, and the resulting pellets were used for 
ADP-ribosylation of Gi proteins as described above. 
2.4. lmmunoprecipitation a d phosphorylation of Gi pro- 
teins 
The tissue membranes were solubilized in 1% Triton 
X-100, 20 mM Tris-HC1 buffer (pH 7.4), 125 mM NaC1, 1 
mM MgCI 2, 1 mM CaC12, 10 p~g/ml aprotinin, 10 p,g/ml 
leupeptin at 4°C for 1 h with gentle stirring by the method 
of Der et al. [12], then centrifuged at 9000 × g for 10 min 
at 4°C to remove non-solubilized material. The resulting 
supernatants were incubated with a 1/20 dilution of AS/7 
for 12 h and applied to a column of Protein A-Sepharose 
CL-4B (1.5 cm X 2.0 cm) pre-equilibrated with 20 mM 
sodium phosphate buffer (pH 7.0). The immune complex 
was eluted at the flow rate of 0.2 ml/min with 100 mM 
glycine-HCl buffer (pH 2.7). After dialysis against H20, 
the eluate was concentrated. Aliquots of the samples were 
added to phosphorylation mixture consisting of 20 mM 
Hepes buffer (pH 7.5), 10 mM MgC12, 2 mM DTT, 10 
Ixg/ml aprotinin, 10 Ixg/ml leupeptin, 10 I.LM [~- 32 P]ATP 
(1500 cpm/nmol) and PKA catalytic subunit (20 units), 
and incubated for 30 min at 30°C. The reaction was 
stopped by addition of TCA at a final concentration of 
16%. After centrifugation at 150 000 X g for 30 min, the 
pellets were dissolved, without heating, in solubilizing 
buffer as described above and subjected to SDS-PAGE in 
10% linear polyacrylamide g ls. After electrophoresis, the 
gels were auto-radiographed and the areas of absorbance 
of the bands were measured with a chromatoscanner. In 
some experiments, parotid glands were obtained from male 
Wistar rats given [ 32 P]orthophosphate (15.8 TBq/100 g 
body wt.) i.p. 1 h before experiments o obtain radiola- 
beled Gi proteins and used for preparation of the tissue 
slices. The membranes prepared from the tissue slices after 
IPR treatment were solubilized and incubated with AS/7. 
The radioactivity of the immune complex obtained as 
described above was measured. 
2.5. Binding of [35S]GTPyS 
The binding activity of G proteins with [35S]GTP~S 
was measured according to the method of Avissar et al. 
[13]. The membranes (400 mg protein), precipitated by 
centrifugation after the ADP-ribosylation reaction as de- 
scribed above, were suspended in 880 Ixl of 25 mM 
Tris-HC1 buffer (pH 7.4), 1 mM ATP, 0.1 mM MgC12, 1 
mM EGTA (pH 7.4), 1 mM DTT, 100 ~1 of various 
concentrations of [35S]GTP~/S (0.05-5 IxM) and 20 ILl of 
10 I~M unlabeled Gpp(NH)p to determine nonspecific 
binding. The mixture was incubated for 15 min at 22°C 
and the reaction was stopped by addition of 5 ml of 
ice-cold 25 mM Tris-HCl buffer (pH 7.4) containing 1mM 
DTT (buffer B). The mixture was passed through a What- 
man GF/B filter which was then washed three times with 
5 ml of buffer B and then the radioactivity remaining on 
the filter was counted. The specific binding of [3sS]GTP'yS 
was expressed as the difference between the radioactivities 
in the presence and absence of 100 IxM unlabeled 
Gpp(NH)p. Maximal binding sites (Bma x) and the dissocia- 
tion constants (K d) in binding studies were determined by 
Scatchard analysis [14] and by the method of least squares. 
2.6. Statistics 
All data are expressed as mean values __+ S.D. and were 
tested for statistical significance using Student's t-test. 
Values of P < 0.05 were considered to be statistically 
significant. 
2.7. Other methods 
Amylase activity was measured as described by Bern- 
feld [15] with amylose as a substrate, and was expressed as 
maltose liberated into the medium in mg/5 min at 20°C. 
Protein was measured by the method of Lowry et al. [16]. 
Pi was estimated according to the method of Fiske and 
Subbarow [17]. 
2.8. Materials 
[~/-35S]Guanosine 5'-(3,-thio)triphosphate ([35S]GTP~/S, 
45 TBq/mmol), [adenylate -32 P]nicotinamide adenine din- 
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ucleotide ([32 P]NAD, 1.11 TBq/mmol),[ 32 P]orthophos- 
phate (315-337 TBq/mmol) and [~_32p]adenosine 5'-tri- 
phosphatetetra(triethylammonium)salt (ATP, 1 1 1 
TBq/mmol) were obtained from DuPont/New England 
Nuc lear  Co. (Wi lmington ,  USA) .  3-((3- 
Cholamidopropyl)dimethylammonio)- 1-propanesulfonate 
(CHAPS), ethylenediaminetetraacetic acid (EDTA) and 
glycoletherdiaminetetraacedc id (EGTA) were purchased 
from Dojindo Laboratories (Kumamoto, Japan). CT, 5'- 
guanylylimidodiphosphate(Gpp(NH)p), PKA catalytic sub- 
unit, alkaline phosphatase (ALPase), aprotinin and leu- 
peptin were from Sigma Chemical Co. (St. Louis, MO, 
USA). IAP and okadaic acid were from Funakoshi (Tokyo, 
Japan) and Katayama Chemical Industries, Co. (Osaka, 
Japan), respectively. Anti-G protein AS/7 rabbit anti- 
serum (AS/7) was obtained from DuPont (Boston, MA, 
USA). Protein A-Sepharo,;e CL-4B was from Pharmacia 
(Uppsala, Sweden). 
3. Results 
3.1. Effect of period of pretreatment with IPR on ADP- 
ribosylation of G proteins and secretory response to the 
agonist in rat parotid tissues 
Amylase secretion from rat parotid tissues was induced 
by IPR at concentrations of 0.1 txM and above and the 
secretory response was obtained within 2 min, as reported 
previously [6]. Pretreatment of rat parotid tissues with 1 
I~M IPR for 10 min triggered significant enhancement of 
the secretory response to the agonist and the increases in 
amylase secretion during the second incubation, but a first 
incubation period of 30 min conversely suppressed the 
effect of IPR on amylase secretion during the second 
incubation, as shown in Fig. 1, Exp. A and B. As reported 
previously [6], the changes in secretory response of the 
tissues to IPR were strictly dependent on the duration of 
the first incubation with IPR. Rat parotid tissues which had 
been treated without IPR for 10 or 30 min during the first 
incubation showed the same secretory response to IPR 
during the second incubation as that observed in the tissues 
treated with IPR during the first incubation, as reported 
previously [6,8]. Conversely, the tissues which had been 
treated with IPR for 10 or 30 min during the first incuba- 
tion did not secrete amylase from the tissues during the 
second incubation in the absence of the agonist [6,8]. CT 
and IAP catalyzed ADP-ribosylation of Gs and Gi proteins 
in the tissues after the first and the second incubations with 
or without IPR, respectively. No specific labeling of G 
proteins in the tissues was observed in the absence of these 
bacterial toxins (data not shown). Autoradiograms of the 
product of ADP-ribosylation catalyzed by CT showed a 
single protein band with a molecular mass of 45 kDa, 
indicating that CT catalyzed the transfer of ADP-ribose 
from NAD to Gs protein a-subunit (Gsc~ protein) (Fig. 
2-1). IPR produced a 25% increase in the ability of CT to 
catalyze the ADP-ribosylation of Gs proteins in the tissues 
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Fig. 1. Effect of duration of first incubation with IPR on amylase secretion from rat parotid tissues during second incubation with the agonist. Rat parotid 
tissues were incubated with (O) or without (O) 1 IcM IPR for 10 (Exp. A) or 30 (Exp. B) min in the first and second incubations as described in the text. 
Each point represents he mean of three to five experiments + S.D. Insets; amounts of amylase, shown as mg of maltose per 100 mg tissue, secreted by 1 
IxM IPR during the first and second incubations from the tissues. The asterisked values are significantly different between IPR-treated and the control 
values. The asterisked values in insets aresignificantly different from the values obtained uring the first and the second incubations; * P < 0.001. 
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during the first incubation for 10 min, and a 40% increase 
was observed uring the first incubation for 30 min (Fig. 
2-II). However, pretreatment of the tissues with 1 txM IPR 
for 10 or 30 rain had no effect on the ability of CT to 
catalyze ADP-ribosylation of Gs proteins in the tissues 
after the second incubation with the agonist as shown in 
Fig. 2-II. 
On the other hand, IAP catalyzed ADP-ribosylation of a 
single protein band with a molecular mass of 41 kDa in the 
tissues after the first and the second incubations with or 
without 1 IxM IPR, which was detected as a single peak by 
scanning the gel with a thin layer scanner (Fig. 3, Exp. A 
and B-II), indicating the transfer of ADP-ribose from NAD 
to Gi protein a-subunit (Gic~ protein) catalyzed by this 
bacterial toxin. Treatment of the tissues with 1 IxM IPR 
during the first incubation for 10 min triggered a 60% 
decrease in the ability of IAP to catalyze ADP-ribosylation 
of Gi proteins in the tissues after the second incubation 
with the agonist as shown in Fig. 3, Exp. A (I, II)-3 and -4 
(values for area of the peak (41 kDa) measured with an 
image analyzer: 173 _+ 4 and 419 _+ 14 mm2/mg protein in 
the tissues treated with or without 1 ~M IPR, respectively). 
In contrast, increasing the duration of the first incubation 
of the tissues with 1 ~M IPR from 10 to 30 min triggered 
a 40% increase in the ability of IAP to catalyze ADP-ribo- 
sylation of Gi proteins in the tissues after the second 
incubation with the agonist (Fig. 3, Exp. B(I, II)-3 and -4 
(values for area of the peak (41 kDa) measured with an 
image analyzer: 510 _ 46 and 378 _+ 16 mm2/mg protein 
in the tissues treated with or without 1 p~M IPR, respec- 
tively). No changes in the ability of IAP to catalyze the 
ADP-ribosylation of Gi proteins in the tissues were ob- 
served after the first incubation with or without IPR (Fig. 
3, Exp. A and B-I and -2). 
pretreatment for 30 min led to a 20% increase in GTP 
binding ability of Gi proteins, showing an increase in Gi 
protein function (Table 1, Exp. B). However, IPR-induced 
changes in GTP binding ability of Gi proteins were not 
observed uring the first incubation (Table 1, Exp. A and 
B). 
On the other hand, IPR induced 35 and 40% increases 
in GTP binding ability of Gs proteins during the first 
incubation for 10 and 30 rain, respectively, but not during 
the second incubation (Table 1, Exp. A and B). These 
findings show that Gs protein function in the tissues 
increases only during the first incubation with IPR. Signifi- 
cant changes in the K~ values were not observed in the 
tissues incubated with or without 1 ~M IPR during the 
first and second incubations. 
3.3. Effects of  treatment of  rat parotid membranes with 
PKA and ALPase on ADP-ribosylation of  Gi proteins 
Membranes from the tissues after the first and second 
incubations with or without I I~M IPR were incubated 
with PKA catalytic subunit (25 U) in the presence of 1 
mM ATP and 10 mM MgCI 2 to phosphorylate Gie~ pro- 
tein, followed by reaction in ADP-ribosylation medium 
containing [32p]NAD and IAP. Treatment with PKA had 
no effect on the reduction in ability of IAP to catalyze 
( I )  (1) (2) (3) (4) 
" - " , - "  45KDa 
(X) 
3.2. Effect of  period of  pretreatment with IPR on GTP 
binding in rat parotid tissues 
Rat parotid membranes prepared from the tissues after 
the first and second incubations with or without 1 I~M IPR 
specifically bound [35S]GTP~,S and the binding became 
saturated with increases in the concentration of 
[35S]GTP',/S. A Scatchard plot analysis gave a single 
straight line, indicating a single population of binding 
sites. ADP-ribosylation of Gse~ and Gie~ proteins cat- 
alyzed by CT(66 Ixg/ml) and IAP (25 Ixg/ml), respec- 
tively, was performed before [35S]GTP'yS binding experi- 
ments. Gsa and GioL proteins were maximally ADP- 
ribosylated by CT and IAP at the concentrations described 
above, respectively, and resulted in the complete abolish- 
ment of the IPR-induced changes in GTP-binding of the 
respective G proteins (data not shown). IPR pretreatment 
for 10 min led to a 25% decrease in GTP binding ability of 
Gi proteins only during the second incubation as shown in 
Table 1, Exp. A, showing the decrease in Gi protein 
function. In contrast, during the second incubation, IPR 
Values of area (densitometric unit/mg protein) 
First incubation Second incubation 
Exp. 
with IPR / without IPR with IPR / without IPR 
A .371_+25 / 302_+17 342_+17 / 329-+12 
B .423-+13 / 298-+12 277_+18 / 272+_11 
Fig. 2. Effect of duration of first incubation with IPR on ADP-ribosyla- 
tion of Gs proteins. Membranes from rat parotid tissues after the first and 
second incubations with or without 1 txM IPR for 10 (I and II, Exp. A) or 
30 (II, Exp. B) min were incubated in the reaction mixture for ADP-ribo- 
sylation by CT. After SDS-PAGE of CT-catalyzed ADP-ribosylation 
products, the gel was autoradiographed. Theautoradiogram represents a 
typical pattern of CT-catalyzed ADP-ribosylation products in the tissues 
incubated with (1-2 and 4) or without (I-1 and 3) 1 IxM IPR during the 
first (I-1 and 2) and second (I-3 and 4) incubations. The intensity of the 
absorbance of the band with molecular weight of 45 kDa(Gs proteins) in
the autoradiogram was analyzed with a chromatoscanner (II). Values are 
expressed asdensitometric units per mg of protein and show the means of 
three xperiments + S.D. The asterisked values are significantly different 
from their espective control values; * P < 0.001. 
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ADP-ribosylation of GioL protein observed in the tissues 
pretreated with 1 IxM IPR for 10 min during the second 
incubation with the agoni,;t (Table 2, Exp. A), showing 
that the level of phosphorylation of Giot protein in the 
tissues obtained during first incubation for 10 min with 
IPR was still maintained uring second incubation for 10 
min with the agonist. However, the increased ability of 
lAP to catalyze ADP-ribosylation of Gi~x protein observed 
in tissues pretreated with 1 IxM IPR for 30 min during the 
second incubation with the agonist disappeared completely 
following this treatment (Table 2, Exp. B), showing that 
the phosphorylation level of Gicx protein in the tissues 
during the first incubation with IPR for 30 min was 
markedly decreased to the level in the tissues treated 
without IPR and did not increase during the second incuba- 
tion with IPR. On the other hand, the increased ability of 
CT to catalyze ADP-ribosylation of Gse~ protein in the 
tissues pretreated with 1 I~M IPR for 10 or 30 min during 
the first incubation was not affected by treatment with 
PKA (data not shown). In contrast, pretreatment of the 
tissue membranes with ALPase (0.5 and 1.0 U) triggered 
an increase in the ability of IAP to catalyze ADP-ribosyla- 
tion of Gia protein in the tissue membranes after the first 
and second incubations with l IxM IPR for l0 or 30 min in 
a manner dependent on the dose of the enzyme (Table 2, 
Exp. A and B). The amounts of Pi removed from the tissue 
membranes paralleled the increases in IAP-catalyzed 
ADP-ribosylation of Gia protein.These findings indicate 
Exp.A 
( I )  
(1) (2) (3) (4) 
-..~-41KDa 
(1T) 
(+) ~ (2) 
(3) + (4) 
Exp,B 
(X) (It) 
(1) (2) (3) (4) 
(I) + (+,) ,+ 
--'~-41KDa + (3) + 
Fig. 3. Effect of duration of first incubation with IPR on ADP-ribosylation f Gi proteins. Membranes from rat parotid tissues after the first and second 
incubations with or without 1 IxM IPR for l0 (Exp. A) or 30 (Exp. B) min were incubated in the reaction mixture for ADP-ribosylation bylAP. After 
SDS-PAGE of the ADP-ribosylation products, the location and intensity of the radioactive peptides on the gel were analyzed using a thin layer scanner 
(Exp. A and B-II) and then autoradiographed (Exp. A and B-II). The arrows in Exp. A and B indicate the positions of 41 kDa (Gia protein). 
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Table 1 
Effect of IPR treatment on GTP binding activity of Gs and Gi proteins in rat parotid tissues 
[ 35 S]GTP~/S -binding (B . . . .  pmol /mg protein) 
Exp. Toxins First incubation: Second incubation: 
without IPR with IPR without IPR with IPR 
A CT 36.4 + 0.9 36.7 + 0.9 42.4 + 0.3 32.0 + 1.6 ~ 
(194.3 + 0.1) (195.9 ___ 3.1) (204.6 + 3.0) (198.3 __+ 15.5) 
lAP 31.0 _+ 1.4 41.4 + 1.2 a 33.6 + 3.7 33.9 + 3.5 
(211. I + 4.8) (207.7 __+ 11.9) (195.6 + 0.5) (198.2 ___ 4.5) 
B CT 39.7 ___ 2.1 41.1 ___ 1.5 34.2 + 0.1 41.1 + 0.1 a 
(217.8 + 12.1) (203.6 + 9.6) (201.6 + 1.6) (211.3 + 16.3) 
IAP 32.6 + 2.3 45.6 + 2.5 ~ 37.1 + 1.5 37.3 + 1.7 
(191.9 + 10.5) (203.7 + 8.7) (230.3 + 19.2) (218.3 + 9.6) 
Rat parotid tissue membranes after the first and second incubations for 10 (Exp .A) and 30 (Exp. B) min with or without 1 l.zM IPR were reacted with CT 
or IAP, and then incubated in medium containing [35S]GTP~/S as described in the text. Bma x values, and Ko values (nmol) shown in parentheses, are the 
means of three to five experiments + S.D. The asterisked values are significantly different from their respective control values; a p < 0.00l. 
that the regu la t ion  o f  phosphory la t ion  o f  Giet  p ro te in  
cont ro l s  ADP- r ibosy la t ion  o f  the  prote in .  
3.4. Effect of pretreatment of rat parotid tissues with 
okadaic acid on secretory response of the tissues and 
ADP-ribosylation of Gi proteins 
3.4.1. Amylase secretion 
Parot id  t i ssues  wh ich  had  been  pret reated  w i th  0.05 to 
0.2 I~M okada ic  ac id  were  reacted  w i th  1 IxM IPR  dur ing  
the f irst and  the second incubat ions .  As  shown in Tab le  3, 
Exp .  A and  B, p re t reatment  o f  the t i ssues  w i th  okada ic  
ac id  caused  both  enhancement  o f  IPR- induced  supersens i -  
t iv i ty  o f  amylase  secret ion  f rom the t i ssues  and  abo l i sh -  
ment  o f  IPR- induced  desens i t i za t ion  observed  dur ing  the 
second incubat ion .  However ,  okada ic  ac id  pre t reatment  o f  
the t i ssues  d id  not  p roduce  any  change  in the  amount  o f  
amylase  secreted  dur ing  the f i rst  incubat ions  for  10 and  30 
min  w i th  or  w i thout  IPR  (Tab le  3, Exp .  A and  B).  These  
e f fec ts  o f  p re t reatment  w i th  okada ic  ac id  on  amylase  secre-  
Table 2 
Effect of treatment with PKA or ALPase of rat parotid membranes on ADP-ribosylation of Gi~x protein 
Exp. Treatment ADP-ribosylation of Gic~ protein (mm2/mg protein) 
First incubation: Second incubation: 
without IPR with IPR without IPR with IPR 
PKA (U) 
- 350 + 12 354 + 32 419 + 14 173 + 4 
25 369 + 28 374 + 37 434 _+ 13 203 + 12 
ALPase (U) 
- 498 + 63 324 + 49 
(1.21 _+ 0.12) (1.09 + 0.09) 
0.5 775 ___ 39 " 658 _+ 21 " 
(2.39 + 0.06 ~ (2.78 _+ 0.12 a) 
1.0 1080 +_ 56 ~ 992 + 31 ~ 
(3.76 __. 0.06 ") (3.76 + 0.06 ~) 
PICA (U) 
- 392 + 22 400 + 24 378 _ 16 510 ___ 46 
25 395 + 9 391 + 35 395 + 14 401 + 57 b 
ALPase (U) 
- 163 + 31 243 + 27 
(1.16 + 0.08) (1.11 + 0.03) 
0.5 356 + 40 a 364 + 44 a 
(2.30 ___ 0.06 a) (2.14 + 0.11 a) 
1.0 568 + 60 ~ 600 + 22 ~ 
(3.52 + 0.07 ~) (3.29 --- 0.15 ~) 
Rat parotid tissue membranes after the first and second incubations with or without 1 I.zM IPR for 10 (Exp. A) or 30 (Exp. B) min were reacted with PKA 
or ALPase and then used for lAP-catalyzed ADP-ribosylation of Gict protein. After SDS-PAGE of the ADP-ribosylation products, the location and 
intensity of the radioactive peptides on the gel were analyzed using a thin layer scanner, and areas under the peaks (41 kDa) on the radiogram were 
measured as described in the text. The numbers in parentheses indicate the amounts of Pi Qxmol/mg protein) removed by ALPase. Values are the means 
of three to five experiments ___ S.D. The asterisked values are significantly different between PKA- or ALPase-treated values and the control values; 
a P<0.001,  bp<0.01 .  
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Table 3 
Effect of pretreatment with okadaic acid on amylase secretion from rat parotid tissues and ADP-ribosylation of Gi proteins of the tissues 
153 
Exp Okadaic acid Amylase secreted (mg maltose/100 mg tissue) 
First incubation 
(with IPR/without IPR) 
Second incubation 
(with IPR/without IPR) 
ADP-ribosylation of Gict protein (mm2/mg protein) 
First incubation 
(with IPR/without IPR): 
Second incubation 
(with IPR/without IPR): * * 
A None 145 5- 10/59 ___ 6 208 4- 6/53 4- 5" 354 + 32/350 + 12 173 4- 4/419 + 14 
0.05 146 :k 4 /64  5:6 248 + 8/57 + 4* * * 
0.1 144 4- 4 /57 + 3 332 4- 2/55 + 1" 310 + 17/315 4- 15 89 4- 15/281 + 8 
0.2 166 :k 3 /66 _ 3 369 +_ 19/61 ± 5 * * 
None 420 4- 4/100 4- 6 206 4- 5 /94 ± 7 ~ 400 + 24/392 _+ 22 510 4- 46/378 _ 16 
0.05 427 4- 22/116 _+ 3 323 _+ 3/101 _ 2* 
B 0.1 423 4- 4 /98 4- 5 439 4- 2/98 ± 6" 243 + 13/255 4- 20 250 4- 16/236 _ 14 
0.2 448 4- 14/132 ± 9 449 ± 23/116 _+ 14 
Rat parotid tissues which had been pretreated with okadaic acid at concentrations between 0.05 and 0.2 ~M were incubated with or without 1 I~M IPR for 
10 (Exp. A) or 30 (Exp. B) min in the first and second incubations. The membranes from the tissues after the incubations were reacted with IAP. After 
SDS-PAGE of the ADP-ribosylation products, the location and intensity of the radioactive peptides on the gel were analyzed using a thin layer scanner. 
The areas under the peaks (41 kDa) on the autoradiogram were measured and expressed as described in the text. Each value represents he mean of three to 
five experiments + S.D. The single and double asterisked values are significantly different between okadaic acid-treated and the control values, and 
IPR-treated and the control values respectively; * P, * * P < 0.001. 
tion from the tissues in response to IPR during the second 
incubation were dose-dependent be ween 0.05 and 0.2 txM 
(Table 3, Exp. A and B). These findings indicated that 
okadaic acid markedly enhanced IPR-induced supersensi- 
tivity of amylase secretion from parotid tissues, and com- 
pletely abolished IPR-induced desensitization f amylase 
secretion from the tissues. 
3.4.2. ADP-ribosylation of Gia protein 
Pretreatment of parotid tissues with 0.1 IxM okadaic 
acid enhanced the IPR-induced ecrease in IAP-catalyzed 
ADP-ribosylation of Gia protein, but completely blocked 
the IPR-induced increase (Table 3, Exp. A and B). These 
( I )  (1) (2)(3)(4)(5) (X )  
150- 
o o ¢ (g e~ 
100- 
~41KDa .~ 
50" m 
< 
/ 
o 16o 2oo 
Protein (jJg) 
Fig. 4. Stoichiometry of the phosphorylation of Gi2et protein of rat 
parotidtissues by PKA. 50 (I-l), 90 (I-2), 130 (1-3), 170 (I-4) and 210 
(I-5) p,g of immunoprecipitates with AS/7  were incubated with PKA 
catalytic subunit in the presence of [~/-32 P]ATP. MgCl 2. After SDS-PAGE 
of the phosphorylation products, the gel was autoradiographed. A typical 
autoradiogram pattern (I) and the amounts of radioactivity incorporated 
into the various concentrations of the immunoprecipitates with AS/7(II) 
are shown. Each point represents he mean of four experiments + S.D. All 
data were evaluated by analysis of variance; (F  ratio = 65.0, P < 0.001). 
( I ) Exp.A Exp.B 
(1) (2) (3) (4) (1) (2) (3) (4) 
( l r )  
Stolchiometry of [=~P] labelng of Gi2a protein 
( xl04cpmlmg protein) 
First Incubation Second incubation 
Exp. 
with IPR / without IPR with IPR / without IPR 
A 2.86__.0.30 / 2.95+0.32 *3.75+_0.37 / 2.77_+0.25 
B 6.20+_0.74 / 6.36_+0.15 *.3.21_+0.44 / 5.89_+1.12 
Fig. 5. Effect of IPR treatment on the stoichiometry of phosphorylation f 
Gi2ct prot.ein Parotid tissues from rats injected with [32 P]orthophosphate 
were pretreated with 0.1 i.tM okadaic acid and then incubated with (I-2 
and 4) or without (I-1 and 3) 1 IxM IPR during the first and second 
incubations for 10 min (Exp. A). In Exp. B, tissues which had not been 
pretreated with okadaic acid were incubated with (I-2 and 4) or without 
(1-1 and 3) 1 IzM IPR during the first and second incubations for 30 min. 
After SDS-PAGE of immunoprecipitates with AS /7  from the tissues, the 
gel was autoradiographed (I). The radioactivity associated with the im- 
munoprecipitates with AS /7  from the tissues was solubilized and then 
measured as described in the text (II). The values indicate the means of 
three experiments + S.D. The asterisked values are significantly different 
from their respective control values; * P < 0.001, * * P < 0.01. 
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findings support the results concerning the effects of 
okadaic acid pretreatment of parotid tissues on the IPR-in- 
duced supersensitivity and desensitization of amylase se- 
cretion described above. 
3.5. Determination of the stoichiometr), ofphosphoo'lation 
of Gi2 ~ protein by PKA 
To determine the stoichiometry of phosphorylation of 
Gi2oL protein in rat parotid tissues, immunoprecipitates 
with AS /7  from the tissues were incubated with PKA 
catalytic subunit in the presence of [-/-32 P]ATP and MgCI 2 . 
Autoradiogram of the phosphorylated immunoprecipitates 
showed a single protein band with a molecular mass of 41 
kDa, namely Gi2oL protein, and the intensity of radiola- 
beled substrate for PKA was dependent on the amount of 
the protein used for reaction with the enzyme (Fig. 4-I). 
The intensity of radioactivity associated with Gi2 eL protein 
increased in proportion to the content of the immunopre- 
cipitate used for the phosphorylation reaction with PKA 
(Fig. 4-II), indicating that there were sites for PKA-media- 
ted phosphorylation on Gi2e~ protein in the tissues. 
3.6. Effects of IPR treatment on the stoichiometry of 
phosphorylation of Gi2 e~ protein 
To estimate whether the phosphorylation site on Gi2e~ 
protein in rat parotid tissues might be affected by IPR 
treatment, we examined the effects of IPR treatment on the 
stoichiometry of labeling of Gi2oL protein in the tissues of 
rats which had been given [32 P]orthophosphate. Autoradio- 
gram of the immunoprecipitate with AS /7  from the tissues 
treated with or without IPR during the first and second 
incubations howed a single protein band with a molecular 
mass of 41 kDa, indicating that Gi2o~ protein was markedly 
and rapidly phosphorylated in rat parotid gland cells (Fig. 
5-I, Exp. A and B). The intensity of radiolabeled Gi2e~ 
protein was not affected by IPR in either of the tissues 
during the first incubations for 10 and 30 rain (Fig. 5-I and 
-II, Exp. A and B). However, analysis of the intensity 
showed a 40% increase during the second incubation with 
1 IxM IPR in the tissues pretreated with 0.1 txM okadaic 
acid which caused IPR-induced supersensitivity of amylase 
secretion enhancement and then treated with the agonist 
for 10 min during the first incubation (Fig. 5-I and II, Exp. 
A). In marked contrast, the intensity showed a 50% de- 
crease during the second incubation with 1 IxM IPR in 
tissues which had not been pretreated with 0.1 IxM okadaic 
acid and then treated with the agonist for 30 min during 
the first incubation (Fig. 5-I and II, Exp. B). These find- 
ings indicate that IPR causes changes in the phosphoryla- 
tion level of Gi2c~ protein in rat parotid tissues and then 
changes in ADP-ribosylation of the protein. 
3.7. Effects of IPR treatment on the time course of phos- 
pho~lation of Gi2c~ protein and amylase secretion 
As shown in Fig. 6, the onset of the IPR-induced 
increase in phosphorylation f the immunoprecipitates with 
AS /7  from tissues which had been pretreated with 1 p,M 
IPR for 10 min preceded temporally the initiation of 
amylase secretion. This finding shows that the phosphory- 
lation of Gi2ot protein is directly involved in the regula- 
tion of the cellular response of rat parotid tissues. 
IOO0 
-=i ~ 800 
g. 
~. 6oo 
== ,oo 
2OO 
Q. 
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1.5 3 6 1'0 
Time (min) 
I 150 
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Fig. 6. Typical time-courses of the phospborylation of Gi2~ protein and 
amylase secretion. Parotid tissues from rats injected with [32 P]orthophos- 
phate were incubated with l p,M IPR for 10 rain during the first 
incubation and then incubated with the agonist for various times during 
the second incubation. Cumulative amylase secreted into medium was 
determined and the tissue membranes were obtained. The immunoprecipi- 
tates with AS/7 and their adioactivity were measured at intervals during 
the second incubation as described inthe legend of Fig. 5. All data were 
evaluated by analysis of variance; for pbosphorylation level of Gi2c~ 
protein (F ratio = 38.8, P < 0.001 );for amylase activity (F ratio = 20.4, 
P < 0.001). 
4. Discussion 
We reported previously that short-term pretreatments of
rat parotid tissues with 1 p,M IPR for 10 and 30 min 
resulted in the supersensitivity and the desensitization of 
amylase secretion from the tissues, respectively. These 
phenomena were coupled with changes in the number of 
13-adrenoceptors n the tissues and in their affinity for their 
agonists, but not with any concomitant changes in the level 
of cyclic AMP in the tissues [6], suggesting the importance 
of the postreceptor mechanism. The rapid change in secre- 
tory response to IPR from supersensitivity o desensitiza- 
tion was strictly dependent on the duration of the first 
incubation with the agonist [6], and this change was ob- 
served only in rat parotid tissues, but not in rat submandib- 
ular tissues [8]. Secretory response to IPR in the second 
incubation of rat parotid tissues which had been treated 
without IPR for 10 or 30 rain in the first incubation was 
exactly similar to that of the tissues which reacted to IPR 
in the first incubation. It was reported that the ECs0 value 
(the value of 50% effective concentration) of IPR on 
amylase secretion from the tissues was 100 nM [6]. This 
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dose caused secretion of 31)% of the total amylase in the 
tissues [18] and 10 ~M IPR showed the maximal effect on 
amylase secretion [19]. These findings show that 1 ixM 
IPR is a physiologically relevant dose. 
It has been shown that G proteins play a key role in 
transmembrane signal transduction as coupling proteins, 
and transduce information from a variety of membrane 
receptors to respective ffi~ctor proteins. Gs, Gi and Gq 
have been identified in the rat parotid gland [20,21]. 
[3-Adrenoceptors are coupled with the carboxyl-terminus 
of Gs~ protein, and binding of [3-agonists with the [3- 
adrenoceptor promotes activation of Gs proteins [22]. 
Functional modifications and decreases in Gs protein lev- 
els were suggested to be involved in agonist-induced het- 
erologous desensitization of AC stimulation in erythro- 
cytes [23] and hepatocytes [24]. In the present study, IPR 
produced 25 and 40% increases in the ability of CT to 
catalyze ADP-ribosylation of Gs proteins in parotid tissues 
during first incubations fol: 10 and 30 min, respectively, 
indicating increases in the apparent levels of the active 
forms of Gs proteins in the tissues. However, changes in 
the levels and function of Gs proteins, measured as CT- 
catalyzed ADP-ribosylation and GTP binding capacities of 
these proteins, were not involved in the mechanism under- 
lying either the IPR-induced supersensitivity or desensiti- 
zation of amylase secretion from rat parotid tissues (Table 
1, Exp. A and B and Fig. 2-I and II). This finding was 
supported by our previous observation that the level and 
function of Gs proteins were enhanced only during the first 
incubation of rat submandibular tissues with IPR, but were 
not altered during the second incubation with the agonist, 
and were not involved in ~:he IPR-induced desensitization 
of mucin secretion [8]. 
It has been shown that three highly related IAP-sensi- 
tive G proteins termed Gi 1, Gi2 and Gi3 comprise a family 
of Gi proteins [25,26] and that Gi2 may act as G protein to 
inhibit AC activity [27]. Increases in the level and function 
of Gi proteins, measured as IAP-catalyzed ADP-ribosyla- 
tion and GTP binding capacities of these proteins, have 
been demonstrated in agonist-induced desensitization of 
AC stimulation in MDCK cells [28], rat heart muscle cells 
[29] and rat submandibular tissues [8]. In this study, we 
showed clearly that decreases and increases in Gi protein 
level and GTP binding capacity were involved in the 
mechanism underlying the IPR-induced supersensitivity 
and desensitization f amylase secretion from rat parotid 
tissues, respectively (Table 1, Exp. A and B and Fig. 3-I 
and II). 
Activation of Gs proteins leads to the activation of 
PKA, suggesting the importance of PKA in the regulation 
of G protein function. I1: has been reported that Gic~ 
protein is phosphorylated byPKA [11,30]. This phosphory- 
lation causes some confonnational changes in the Gi pro- 
tein trimers, and decreases in both the IAP-catalyzed 
ADP-ribosylation of Gi proteins and their dissociation i to 
et- and ~/-subunits. Treatment of rat parotid membranes 
with PKA in the presence of ATP-Mg 2+ or ALPase 
caused a decrease or an increase in lAP-catalyzed ADP- 
ribosylation of Gie~ protein in the tissues, respectively 
(Table 2, Exp. A and B). Also, immunoprecipitates with 
AS/7 from rat parotid tissues were markedly phosphory- 
lated (Figs. 4 and 5-I and II). AS/7 can immunoprecipitate 
Gi2 selectively [31]. Two isozymes of PKA, types I and II, 
have been identified in the rat parotid gland [32]. PKA 
type I, the membrane bound form, is activated during 
[3-adrenergic stimulation and accompanied by an increase 
in specific membrane protein phosphorylation during amy- 
lase secretion induced by [3-agonists. It was reported that 
cAMP levels in mouse parotid tissues were very low under 
resting conditions but showed a rapid and a dose-depen- 
dent increase after the intraperitoneal injection of IPR [33]. 
It is, therefore, suggested that Gi2c~ protein is selectively 
phosphorylated by PKA type I, resulting in a decrease in 
its function. The onset of the phosphorylation reaction of 
Gi2a protein temporally preceded the initiation of amy- 
lase secretion (Fig. 6). This finding was supported by the 
observation that the increase in phosphorylation f Gi2cx 
protein paralleled the reduction in Gi protein function 
which preceded maximal phosphorylation [31]. Okadaic 
acid treatment caused rapid time- and concentration-depen- 
dent increases in the phosphorylation f Gi2e~ protein in 
[32P]Pi-labeled intact rat hepatocytes [34]. In rat parotid 
tissues, treatment with okadaic acid at a concentration 
which inhibited protein phosphatase types I and IIA [35] 
caused an increase in phosphorylation f Gi2c~ protein and 
resulted in enhancement of the secretory response to IPR 
in the tissues (Table 3, Exp. A and B and Fig. 5-I). 
Phosphorylation by PKA of specific serine residue on 
G-subunit of protein phosphatase type I inhibited the activ- 
ity by dissociation of the catalytic subunit from G-subunit 
[36]. And also inhibitor I, an inhibitor of protein phos- 
phatase type I, was phosphorylated through the activation 
of PKA by adrenaline and resulted in a inhibition of the 
activity [36], indicating that the activity of protein phos- 
phatase type I is inhibited through the activation of PKA 
by cAMP elevation, and protein phosphatase type IIA may 
be involved in dephosphorylation f Gi2e~. On the other 
hand, it was reported that cAMP may contribute to the 
regulation of the activity of protein phosphatase type IIA 
because of the detection of a consensus equence for 
cAMP response lement binding protein on promoter e- 
gion of the enzyme and that enzyme activity was increased 
by forskolin [37]. These findings indicate that the function- 
ing of Gi2e~ protein is regulated ynamically by phospho- 
rylation and dephosphorylation system involving PKA and 
protein phosphatase types I and IIA, and its phosphoryla- 
tion is directly involved in the regulation of cellular re- 
sponses in rat parotid tissues. In summary, we demon- 
strated here that Gi proteins were targets for the modula- 
tion of cellular esponses under the IPR-induced supersen- 
sitivity and desensitization of amylase secretion from rat 
parotid tissues, and that the rapid turnover of phosphate on 
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Gi2o~ protein played a prominent role in the modulation of 
cellular esponses. 
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